Judicial Watch has uncovered a study by Pfizer/BioNTech that found the lipid nanoparticles (LNP’s) used in its Covid-19 vaccine left the injection site in test animals and moved to various organs of the body, including the liver, adrenal glands, spleen […]
An update on our coverage of the Alzheimer’s drug Aduhelm. And a resident of San Francisco’s drug-riddled Tenderloin District talks about the nightmarish turn she says the neighborhood has taken with the City’s permission.
After Hours: Alzheimer’s Drug Update & San Francisco’s Open-Air Drug Market (Podcast) Read More »
Top officials at the U.S. Food and Drug Administration (FDA) say Americans may need an annual Covid-19 shot, just like getting an annual flu shot. They say vaccines will likely be updated each year to head off the latest variant.
(READ) FDA says annual Covid-19 shot may be part of the ‘new normal’ Read More »
The chief executive of the drug company that created one of the most controversial drugs in the history of FDA approval is resigning, according to reports. Michael Vounatsos presided over Biogen during a rocky time during which the company halted,
CEO of company that makes miracle Alzheimer’s-drug-gone-wrong resigns Read More »
The following is an excerpt from Just The News. The mRNA Covid-19 vaccines made by Pfizer and Moderna showed no reduction in all-cause mortality in randomized controlled trials (RCTs), according to a new paper by researchers at primarily Danish institutions.
Study: Pfizer, Moderna Covid vaccines don’t reduce ‘all-cause’ deaths Read More »
Medicare will only pay for patients to take a controversial new Alzheimer’s drug if they are enrolled in an approved study. That policy decision from the federal government is the latest blow to aducanumab, being sold by Biogen under the
The following is an excerpt from MedPage. All the FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) could agree about on Wednesday in terms of a plan for Covid boosters is that they need more data. FDA staff charged VRBPAC
FDA panel mulls over Covid booster issues despite ‘insufficient data’ Read More »
Sen. Ron Johnson (R-Wisconsin) has sent yet another letter to the heads of all US public health agencies seeking answers to questions regarding the federal government response to Covid-19. Johnson sent his letter to the Secretary of the Department of
